Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition |
St. Jude Children’s Research Hospital / Adam Durbin, PhD |
Young Investigator Grants |
2018 |
Tennessee |
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD |
Young Investigator Grants |
2023 |
Ohio |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute / Vishal Khairnar, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |
Micro-environmental Regulators of Ewing sarcoma Metastasis |
University of Pittsburgh / Kelly Bailey, MD/PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children’s National Medical Center / Suzanne Miles |
Young Investigator Grants |
2009 |
District of Columbia |